Neoplasms

3,880 trials 1,551 recruiting

Filter these 3,880 trials by phase, country and sponsor.

Open in Search →

First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors Ended

2024-517984-21-00 Advanced Solid Tumors 1
Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Nonsmall cell lung cancer Ended

2024-516189-12-00 Patients affected by Resectable Head and Neck (HN) canc 4
C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended

2024-517988-23-00 KRAS mutated advanced solid tumors 1
Phase 1/2 Study of Belzutifan Plus Palbociclib Versus Belzutifan in Advanced Renal Cell Carcinoma (RCC) Ended

2023-504963-17-00 Advanced ccRCC 9
NXP800 in subjects with Ovarian Cancer Ended

2023-509150-64-00 Platinum-resistant, ARID1a-mutated ovarian, fallopian t 1
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlle… Ended

2025-520735-16-00 CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX 4
MK-1200 for Advanced Solid Tumors Ended

2023-508684-68-00 Advanced solid tumor 9
A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers Ended

2023-507674-41-00 Advanced high-grade serous ovarian cancer (OC) 1
Brightline-4: A study to test how well brigimadlin is tolerated by people with a type of cancer called dedifferentiated liposarcoma Ended

2023-504522-19-00 dedifferentiated liposarcoma 5
Study of SKB264 in patients with advanced and hard-to-treat cancers who have not responded well to standard treatments. Ended

2023-508700-38-00 Metastatic or locally advanced unresectable solid tumor 4
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lun… Ended

2024-519651-28-00 metastatic squamous non-small cell lung cancer 1
A study to investigate the safety, tolerability, pharmacokinetics (PK), and preliminary anticancer activity of GSK4524101 alone or with nira… Ended

2024-520197-36-00 Neoplasms 7
A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Nonsquamous non-small cell lung cancer 4
Phase 1 study of NG-350A plus pembrolizumab in metastatic or advanced epithelial tumours (FORTIFY) Ended

2023-503457-35-00 Epithelial tumours 9
A Phase II study evaluating efficacy of KTE-X19 CAR-T cell therapy in Relapsed or Refractory Mantle-Cell Lymphoma achieving a partial respon… Expired

2022-502907-31-00 Relapsed or Refractory Mantle-Cell Lymphoma 4 2023-12-28
A multicentric phase II trial evaluating volrusotmig in patients with mature tertiary lymphoid structures solid tumors. Expired

2023-503451-94-00 Adult participants with metastatic (advanced) solid tum 4